logo
welcome
TipRanks

TipRanks

Novartis’ Gene Therapy Shows Promise in Treating SMA

TipRanks
Summary
Nutrition label

79% Informative

Novartis announced the success of its Phase III STEER study for treating spinal muscular atrophy ( SMA ) Type 2 in children and young adults.

The study demonstrated an increase in motor function, showcasing the therapy’s efficacy and safety compared to a sham control.